AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Report for October

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 950 shares, an increase of 104.3% from the September 30th total of 465 shares. Based on an average daily volume of 463 shares, the days-to-cover ratio is presently 2.1 days. Approximately 0.0% of the shares of the stock are short sold.

AB Corporate Bond ETF Price Performance

Shares of AB Corporate Bond ETF stock traded up $0.01 during mid-day trading on Friday, reaching $33.88. 904 shares of the stock were exchanged, compared to its average volume of 556. The company has a market cap of $27.10 million, a price-to-earnings ratio of -20.16 and a beta of 0.20. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.01. The firm has a 50-day simple moving average of $33.90 and a 200 day simple moving average of $34.94. AB Corporate Bond ETF has a fifty-two week low of $33.24 and a fifty-two week high of $36.46.

AB Corporate Bond ETF Increases Dividend

The company also recently disclosed a monthly dividend, which was paid on Tuesday, October 6th. Shareholders of record on Thursday, October 1st were paid a dividend of $0.1367 per share. This is a positive change from AB Corporate Bond ETF’s previous monthly dividend of $0.1284. This represents a $1.64 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend was Thursday, October 1st. AB Corporate Bond ETF’s payout ratio is currently -101.79%.

AB Corporate Bond ETF Company Profile

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.